<p>Listen to cytomegalovirus (CMV) experts discuss how to educate parents whose newborn has tested for positive for congenital CMV  Credit available for this activity expires: 08/18/23 Earn Credit / Learning Objectives & Disclosures: <a href= "https://www.medscape.org/viewarticle/979328?src=mkm_podcast_series_979328"> https://www.medscape.org/viewarticle/979328?src=mkm_podcast_series_979328</a></p>

What You Need to Know About Screening Newborns for Cytomegalovirus

In the United States, cytomegalovirus (CMV) is the leading congenital viral infection, affecting approximately 1 in every 200 babies. Fortunately, in most cases, patients have no symptoms or disabilities. However, about 10% of the newborns who test positive are symptomatic. In these patients, congenital CMV can be associated with long-term neurodevelopment sequelae, such as sensorineural hearing loss, cerebral palsy, and intellectual disability. Listen to experts in this podcast series discuss what clinicians need to know about congenital CMV, including pathophysiology, evolution in pregnancy, newborn screening, a patient's experience, prevention strategies, and how to build a healthcare team.